Traumatic Brain Injury

banner image

Introducing Traumatic Brain Injury


Traumatic Brain Injury (TBI) occurs from a sudden injury that damages the brain, often resulting from a bump, blow, or jolt to the head. 


The consequences can be far-reaching, leading to a wide range of long-term physical, cognitive, and emotional symptoms.


Common TBI-related symptoms include:

Physical  

Chronic headaches, fatigue, dizziness, and sleep disturbances.

Cognitive  

Memory loss, difficulty concentrating, and "brain fog."

Emotional/Behavioral 

Depression, anxiety, irritability, and Post-Traumatic Stress Disorder (PTSD).



Conventional Treatments for TBI 


Focus on a multidisciplinary approach, including physical, occupational, and cognitive therapies, as well as pharmacological interventions to manage specific symptoms like pain, depression, and anxiety. 


However, these treatments may not be fully effective for all individuals, prompting ongoing research into new therapeutic options like neurostimulation. 

More about Deep TMS for Traumatic Brain Injury?

The Role of TMS in TBI Research:

A Focus on Comorbidities


The hypothesis behind using TMS in this context is that TBI can disrupt brain networks, and TMS may help restore normal function by modulating neural activity


Targeting Depression

TBI-related depression may be a distinct condition from standard Major Depressive Disorder (MDD)

However, some pilot studies using TMS for TBI-associated depression have shown potential for symptom improvement, as TMS may help normalize the altered brain connectivity seen in these patients.


Addressing PTSD 

The H-Coil technology of Deep TMS is designed to stimulate deeper and broader brain regions, which may be beneficial for complex conditions like PTSD.


Research into the use of TMS for TBI is in its early stages. An evidence brief for the U.S. Department of Veterans Affairs (VHA) and other scientific studies have shown mixed results, with some finding that TMS may reduce symptoms in TBI patients, while others found no significant difference compared to a placebo.


This is a rapidly evolving area of neuroscience. The fact that TBI is often an exclusion criterion for many clinical trials highlights the need for more targeted research to establish the safety, efficacy, and optimal treatment protocols for using TMS in this specific patient population.

Attention!

You are viewing a page that is not intended for persons in the United States, and includes information about treatment applications that HAVE NOT BEEN CLEARED by the FDA for safety and efficacy.


However, BrainsWay Deep TMS™ has received the European CE Mark for the treatment of many conditions.

 

This significant approval underscores the therapy's established safety and efficacy for these indications in Europe. While regulatory statuses vary by region, this CE Mark highlights the recognized potential of Deep TMS as a therapeutic option for:


Major Depressive Disorder (MDD)

Anxiety Depression

Obsessive-Compulsive Disorder (OCD)

Smoking Cessation

Alzheimer's Disease (AD)

Autism

Bipolar Disorder

Chronic Pain

Multiple Sclerosis (MS)

Parkinson's Disease

Post-Stroke Rehabilitation

Post-Traumatic Stress Disorder (PTSD)

Negative Symptoms of Schizophrenia

  



See What they said

"I feel different, my cognitive abilities are back, and now I'm enjoying life and even planning to go back to school." 

 — BrainsWay Deep TMS®  Patient 

"My experience with TMS has profoundly changed my life."

— BrainsWay Deep TMS®  Patient

"Feeling in the moment, enjoying life.Now I'm just leading a great life, thanks to  BrainsWay Deep TMS®  for OCD."

— BrainsWay Deep TMS®  Patient